Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)
Augustin, Matthias, Sommer, Rachel, Daudén, Esteban, Laws, Philip, de Jong, Elke, Fabbrocini, Gabriella, Naldi, Luigi, Navarini, Alexander, Lambert, Jo, Reguiai, Ziad, Gerdes, Sascha, Massana, Eric, Obis, Teresa, Kasujee, Ismail, Mrowietz, Ulrich
Published in BMJ open (15.02.2023)
Published in BMJ open (15.02.2023)
Get full text
Journal Article
Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma
Katsaounou, Paraskevi, Odemyr, Mikaela, Spranger, Otto, Hyland, Michael E, Kroegel, Claus, Conde, Lorena Garcia, Gore, Robin, Menzella, Francesco, Domingo Ribas, Christian, Morais-Almeida, Mario, Gasser, Matthias, Kasujee, Ismail
Published in ERJ open research (01.10.2018)
Published in ERJ open research (01.10.2018)
Get full text
Journal Article
44232 Investigator Global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Analysis of PROSES,by race and baseline AV severity
Graber, Emmy, Baldwin, Hilary, Kasujee, Ismail
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
54040 Efficacy of tirbanibulin for the treatment of actinic keratoses (AK): Comparison of results from randomized controlled trials (RCTs) and those from the real-world (RW) PROAK study
Schlesinger, Todd, Kasujee, Ismail, Salem, Raidah, Tomondy, Paul, Bhatia, Neal
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
44248 Patient Reported Outcomes (PROs) assessed using Acne Symptom and Impact Scale (ASIS) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis of PROSES
Alexis, Andrew F., Baldwin, Hilary, Graber, Emmy, Kasujee, Ismail
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
44255 Impact of acne on social functioning, emotional functioning, and activities of daily living(ADL) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis
Alexis, Andrew F., Graber, Emmy, Baldwin, Hilary, Kasujee, Ismail
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
53899 Treatment success with sarecycline for treatment of acne vulgaris (AV): Comparison of results from randomized controlled trials (RCTs) and the real-world (RW) PROSES study
Graber, Emmy, Del Rosso, James, Kasujee, Ismail, Salem, Raidah, Tomondy, Paul, Baldwin, Hilary
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
52742 Real-world patient/clinician-reported outcomes of tirbanibulin for actinic keratosis: indirect comparison between KLIR and PROAK studies
Schlesinger, Todd, Kasujee, Ismail, Tomondy, Paul, Melzer, Antje, Padullés, Laura, Berking, Carola
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
25991 Application of the statistical method to convert published PASI 50/75/90/100 into absolute PASI response rate in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab based on data from two pivotal phase 3 studies (reSURFACE 1/2)
Dykukha, Igor, Schoenenberger, Andreu, Kasujee, Ismail, Mrowietz, Ulrich, Vonthein, Reinhard
Published in Journal of the American Academy of Dermatology (01.09.2021)
Published in Journal of the American Academy of Dermatology (01.09.2021)
Get full text
Journal Article
16310 Dimethyl fumarate as long-term treatment for moderate to severe plaque psoriasis in clinical practice: Interim data from the SKILL study
Kasujee, Ismail, Augustin, Matthias, Kirsch, Astrid, Diemert, Sebastian
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
P107 Clinical priorities when treating psoriasis: insights from a real-world data study of tildrakizumab
Becher, Gabrielle, Stephen, Karen, McInnes, Alison, Heald, Adrian, Riley, Paul, Davies, Mark, Ali, Murad, Kasujee, Ismail
Published in British journal of dermatology (1951) (26.06.2023)
Published in British journal of dermatology (1951) (26.06.2023)
Get full text
Journal Article
Application of the Statistical Method to Convert Published PASI 50/75/90/100 into Absolute PASI Response Rate in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab Based on Data from the Two Pivotal Phase 3 Studies reSURFACE 1 and reSURFACE 2
Dykukha, Igor, Schoenenberger, Andreu, Kasujee, Ismail, Mrowietz, Ulrich, Vonthein, Reinhard
Published in Dermatology (Basel) (2022)
Published in Dermatology (Basel) (2022)
Get more information
Journal Article
33130 Effect of tildrakizumab on work/study-related productivity: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials
Augustin, Matthias, Mrowietz, Ulrich, Du Jardin, Kristian Gaarn, Kasujee, Ismail, Daudén, Esteban
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
52660 Tildrakizumab improves sleep quality and psoriasis-related pruritus and pain in patients with moderate-to-severe plaque psoriasis in conditions close to real clinical practice
Costanzo, Antonio, Cuccia, Aldo, Daudén, Esteban, Fabbrocini, Gabriella, Rivera-Diaz, Raquel, Du Jardin, Kristian Gaarn, Kasujee, Ismail, Puig, Lluís, Carrascosa, José Manuel
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
52653 Real-world effectiveness, quality of life, and treatment satisfaction with tildrakizumab in patients with moderate-to-severe psoriasis: 28-week interim data of the phase IV POSITIVE study
Augustin, Matthias, Sommer, Rachel, Gerdes, Sascha, Weger, Wolfgang, Naldi, Luigi, Ghislain, Pierre-Dominique, de Jong, Elke, Massana, Eric, Kasujee, Ismail, Mrowietz, Ulrich
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
52758 Patient and clinician-reported outcomes with tirbanibulin 1% treatment for actinic keratosis in routine clinical practice across the U.S. according to treated area location (PROAK study)
Schlesinger, Todd, Kircik, Leon, Del Rosso, James, Berman, Brian, Armstrong, April, Bhatia, Neal, Lebwohl, Mark, Patel, Vishal A., Rigel, Darrell, Narayanan, Siva, Kasujee, Ismail
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article